BR112021019189A2 - Antagonistas do receptor de acetilcolina muscarínico subtipo 4 no tratamento de anemia - Google Patents

Antagonistas do receptor de acetilcolina muscarínico subtipo 4 no tratamento de anemia

Info

Publication number
BR112021019189A2
BR112021019189A2 BR112021019189A BR112021019189A BR112021019189A2 BR 112021019189 A2 BR112021019189 A2 BR 112021019189A2 BR 112021019189 A BR112021019189 A BR 112021019189A BR 112021019189 A BR112021019189 A BR 112021019189A BR 112021019189 A2 BR112021019189 A2 BR 112021019189A2
Authority
BR
Brazil
Prior art keywords
anemia
treatment
subtype
acetylcholine receptor
muscarinic acetylcholine
Prior art date
Application number
BR112021019189A
Other languages
English (en)
Inventor
Lingbo Zhang
Al Abed Yousef
Original Assignee
Cold Spring Harbor Laboratory
Feinstein Institutes For Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cold Spring Harbor Laboratory, Feinstein Institutes For Medical Research filed Critical Cold Spring Harbor Laboratory
Publication of BR112021019189A2 publication Critical patent/BR112021019189A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

antagonistas do receptor de acetilcolina muscarínico subtipo 4 no tratamento de anemia. a presente invenção refere-se de forma geral ao tratamento de anemias. mais especificamente, a divulgação refere-se ao uso de antagonistas do receptor de acetilcolina muscarínico subtipo 4, tais como compostos de moléculas pequenas, para promover a autorrenovação de células de unidades formadoras da explosão eritroide (bfu-e) e tratar anemias.
BR112021019189A 2019-03-25 2020-03-20 Antagonistas do receptor de acetilcolina muscarínico subtipo 4 no tratamento de anemia BR112021019189A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962823214P 2019-03-25 2019-03-25
PCT/US2020/023989 WO2020198054A1 (en) 2019-03-25 2020-03-20 Muscarinic acetylcholine receptor subtype 4 antagonists in the treatment of anemia

Publications (1)

Publication Number Publication Date
BR112021019189A2 true BR112021019189A2 (pt) 2021-11-30

Family

ID=72608578

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021019189A BR112021019189A2 (pt) 2019-03-25 2020-03-20 Antagonistas do receptor de acetilcolina muscarínico subtipo 4 no tratamento de anemia

Country Status (12)

Country Link
US (1) US20220185821A1 (pt)
EP (1) EP3946321A4 (pt)
JP (2) JP7558187B2 (pt)
KR (1) KR20210144697A (pt)
CN (1) CN113613650A (pt)
AU (1) AU2020247812A1 (pt)
BR (1) BR112021019189A2 (pt)
CA (1) CA3132381A1 (pt)
IL (1) IL286617A (pt)
MX (1) MX2021011588A (pt)
SG (1) SG11202109857UA (pt)
WO (1) WO2020198054A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500837B2 (en) * 2000-09-22 2002-12-31 Warner-Lambert Company Fused ring system containing indole as M4 selective aza-anthracene muscarinic receptor antagonists
US8329689B2 (en) * 2006-05-23 2012-12-11 Alexandre Vasilievich Ivachtchenko Substituted indoles and a method for the production and use thereof
US20130059783A1 (en) * 2010-03-12 2013-03-07 Johan Flygare Compositions and methods for expanding bfu-e cells
US20210283217A1 (en) 2016-07-26 2021-09-16 Flagship Pioneering Innovations V, Inc. Neuromodulating compositions and related therapeutic methods for the treatment of inflammatory and autoimmune diseases
WO2019010491A1 (en) * 2017-07-07 2019-01-10 University Of Pittsburgh-Of The Commonwealth System Of Higher Education COMBINATIONS OF MEDICINES FOR THE PROTECTION AGAINST THE DEATH OF NEURONAL CELLS

Also Published As

Publication number Publication date
AU2020247812A1 (en) 2021-09-30
EP3946321A1 (en) 2022-02-09
EP3946321A4 (en) 2023-03-08
JP2022525293A (ja) 2022-05-12
WO2020198054A1 (en) 2020-10-01
MX2021011588A (es) 2021-12-15
JP2024102364A (ja) 2024-07-30
CN113613650A (zh) 2021-11-05
US20220185821A1 (en) 2022-06-16
KR20210144697A (ko) 2021-11-30
SG11202109857UA (en) 2021-10-28
CA3132381A1 (en) 2020-10-01
JP7558187B2 (ja) 2024-09-30
IL286617A (en) 2021-10-31

Similar Documents

Publication Publication Date Title
PH12020500509A1 (en) Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
BRPI0508820A (pt) compostos como moduladores de receptor de opióide
PH12018502535A1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
CL2008000212A1 (es) Compuestos derivados de fenotiazina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar diabetes, reducir los niveles de glucemia, adiccion a nicotina, adiccion al alcohol, trastornos del sistema nervioso central, entre
ECSP066669A (es) Indoles, 1h-indazoles, 1,2-benzisoxazoles, y 1,2-benzisotiazoles, y preparación y usos de los mismos
MD3313817T2 (ro) Derivați biciclici, un procedeu pentru prepararea lor și compozițiile farmaceutice care îi conțin
CY1116156T1 (el) Παραγωγα πυριμιδινης συνδεδεμενα με οξυγονο
TW200639173A (en) Substituted pyrazolopyridines, compositions containing same, manufacturing process therefor and use thereof
MX2009010045A (es) Compuestos quimicos.
BR112017009194A2 (pt) tetra-hidropiranos substituídos e método de uso
EA201400311A1 (ru) Аминозамещенные имидазопиридазины
PT2222669E (pt) Derivados de oxadiazole ativos em esfingosina-1-fosfato (s1p)
NZ590650A (en) Buprenorphine analogs
BR112015018087A8 (pt) composto, composição farmacêutica e uso
DE602008005928D1 (de) 1h-indol-3-carbonsäure-chinuclidin-4-ylmethylesterderivate als liganden für den nikotinischen alpha-7-acetylcholinrezeptor zur behandlung von alzheimer-krankheit
TW200738659A (en) Novel compounds
JO2769B1 (en) Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
MY148948A (en) Catecholamine derivatives and prodrugs thereof
MX2010009022A (es) Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
UY37250A (es) Derivados macrocíclicos de indol
UY37971A (es) Derivados de indol macrocíclicos sustituidos
MX2020001979A (es) Macrociclo que contiene aminopirazol y pirimidina y composicion farmaceutica y uso de la misma.
MX2009003645A (es) Azaciclilaminas n-sustituidas como antagonistas de histamina-3.
TW200640857A (en) Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof
UY37972A (es) Derivados de indol macrocíclicos sustituidos con cloro